Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

May Daher

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Journal for Immunotherapy of Cancer|February 27, 2021
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantationChantal Saberian, Noha Abdel-Wahab, Ala Abudayyeh, et al.
Journal for Immunotherapy of Cancer|December 21, 2022
Activated B cells suppress T-cell function through metabolic competitionNobuhiko Imahashi, Rafet Basar, Yuefan Huang, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapyRafet Basar, Nadima Uprety, Emily Ensley, et al.
Biopolymers|December 30, 2014
Meeting report: SMART timing--principles of single molecule techniques course at the University of Michigan 2014Rebecca M Bartke, Elizabeth L Cameron, Ajitha S Cristie-David, et al.
Nature Medicine|September 29, 2022
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escapeYe Li, Rafet Basar, Guohui Wang, et al.
Nature Medicine|January 5, 2024
Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escapeYe Li, Rafet Basar, Guohui Wang, et al.
Blood Cancer Discovery|October 27, 2025
CD70-Targeting CAR-NK Cells Overcome BCMA Downregulation and Improve Survival in High-Risk Multiple Myeloma ModelsPaul Lin, Sunil Acharya, Francia Reyes-Silva, et al.
Nature Medicine|April 4, 2025
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trialYago Nieto, Pinaki Banerjee, Indreshpal Kaur, et al.
Cytotherapy|December 15, 2025
Ex vivo mesenchymal progenitor cell-based cord blood cell expansion and exofucosylation to enhance transplant engraftmentPortia Smallbone, Mayela Mendt, Robert Sackstein, et al.
Cell Reports|July 16, 2021
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapyRafet Basar, Nadima Uprety, Emily Ensley, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Journal for Immunotherapy of Cancer|February 27, 2021
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantationChantal Saberian, Noha Abdel-Wahab, Ala Abudayyeh, et al.
Journal for Immunotherapy of Cancer|December 21, 2022
Activated B cells suppress T-cell function through metabolic competitionNobuhiko Imahashi, Rafet Basar, Yuefan Huang, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapyRafet Basar, Nadima Uprety, Emily Ensley, et al.
Biopolymers|December 30, 2014
Meeting report: SMART timing--principles of single molecule techniques course at the University of Michigan 2014Rebecca M Bartke, Elizabeth L Cameron, Ajitha S Cristie-David, et al.
Nature Medicine|September 29, 2022
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escapeYe Li, Rafet Basar, Guohui Wang, et al.
Nature Medicine|January 5, 2024
Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escapeYe Li, Rafet Basar, Guohui Wang, et al.
Blood Cancer Discovery|October 27, 2025
CD70-Targeting CAR-NK Cells Overcome BCMA Downregulation and Improve Survival in High-Risk Multiple Myeloma ModelsPaul Lin, Sunil Acharya, Francia Reyes-Silva, et al.
Nature Medicine|April 4, 2025
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trialYago Nieto, Pinaki Banerjee, Indreshpal Kaur, et al.
Cytotherapy|December 15, 2025
Ex vivo mesenchymal progenitor cell-based cord blood cell expansion and exofucosylation to enhance transplant engraftmentPortia Smallbone, Mayela Mendt, Robert Sackstein, et al.
Cell Reports|July 16, 2021
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapyRafet Basar, Nadima Uprety, Emily Ensley, et al.
Pageof 9